Literature DB >> 2228814

Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin.

E J Saunders, J A Saunders.   

Abstract

A pregnant woman and the fetus she carries face health risks from many sources. One risk that requires ongoing vigilance is the use of prescription drugs during pregnancy. The international health care community has been sensitized to the risks of drug use during pregnancy because of three pharmaceuticals that have caused widespread crises for mothers and their offspring. The crises that diethylstilbestrol, thalidomide, and, to a lesser extent, Bendectin have created in the past four decades are reviewed in this article. The lessons these drug crises can teach us are articulated in the belief that similar crises may be averted in the future.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228814     DOI: 10.1080/07399339009515912

Source DB:  PubMed          Journal:  Health Care Women Int        ISSN: 0739-9332


  8 in total

1.  Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.

Authors:  Marie-Claude Fournie-Zaluski; Celine Fassot; Bruno Valentin; Dragan Djordjijevic; Annabelle Reaux-Le Goazigo; Pierre Corvol; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

Review 2.  Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options?

Authors:  C N Broussard; J E Richter
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

Review 3.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 4.  Aminopeptidase A inhibitors as centrally acting antihypertensive agents.

Authors:  Laurence Bodineau; Alain Frugière; Yannick Marc; Cédric Claperon; Catherine Llorens-Cortes
Journal:  Heart Fail Rev       Date:  2008-01-03       Impact factor: 4.214

Review 5.  Microphysiological modeling of the reproductive tract: a fertile endeavor.

Authors:  Sharon L Eddie; J Julie Kim; Teresa K Woodruff; Joanna E Burdette
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-15

Review 6.  The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics.

Authors:  J G Coen van Hasselt; Marilee A Andrew; Mary F Hebert; Joel Tarning; Paolo Vicini; Donald R Mattison
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

7.  Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors.

Authors:  Noah R Flynn; Michael D Ward; Mary A Schleiff; Corentine M C Laurin; Rohit Farmer; Stuart J Conway; Gunnar Boysen; S Joshua Swamidass; Grover P Miller
Journal:  Metabolites       Date:  2021-06-15

8.  Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects.

Authors:  Judy L Bolton; Tareisha Dunlap
Journal:  Chem Res Toxicol       Date:  2016-09-29       Impact factor: 3.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.